{"id":690145,"date":"2022-09-29T07:33:18","date_gmt":"2022-09-29T11:33:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/"},"modified":"2022-09-29T07:33:18","modified_gmt":"2022-09-29T11:33:18","slug":"nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/","title":{"rendered":"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>LANGHORNE, Pa., Sept.  29, 2022  (GLOBE NEWSWIRE) &#8212; <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xYIgvLt5YXViKFpis2__1Ef7kDfj_N8JzgxxVZRG_UkKVlchwmHhgxlIKfGIGxX9YEUx-0qsv6kfK53hWoInbQ==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <u>NEXGEL, Inc.<\/u><br \/>\n        <\/a> (\u201cNEXGEL\u201d or the \u201cCompany\u201d) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that the Company has appointed Dr. Neil Chesen and Dr. Leonard Nelson to its Scientific Advisory Board.<\/p>\n<p align=\"justify\">Dr. Nelson serves as Co-Director of the pediatric ophthalmology department and Director of the Strabismus Center at Wills Eye Hospital. He is an associate professor of ophthalmology and pediatrics at Thomas Jefferson University\u2019s Sidney Kimmel Medical College and staff member at Thomas Jefferson University Hospital, Lankenau Medical Center and Children\u2019s Hospital of Philadelphia. Dr. Nelson previously served on staff at St. Christopher&#8217;s Hospital for Children.<\/p>\n<p align=\"justify\">He earned a Doctor of Medicine degree from Harvard Medical School, as well as completed his surgical internship at New England Deaconess Hospital and ophthalmology residency at New York University, Bellevue Hospital Center. He went on to complete a fellowship in pediatric ophthalmology at the Children\u2019s National Hospital of GW University Hospital and fellowship in ocular genetics at the Wilmer Eye Institute of Johns Hopkins Medicine. Additionally, Dr. Nelson obtained his Master of Business Administration degree at St. Joseph\u2019s University and bachelor\u2019s degree in biology from Columbia University. He is the co-editor of the <em>Journal of Pediatric Ophthalmology and Strabismu<\/em>s and authored over 300 publications and 15 textbooks in pediatric ophthalmology. He belongs to the American Association for Pediatric Ophthalmology and Strabismus and American Academy of Ophthalmology, among others.<\/p>\n<p align=\"justify\">\u201cThe NEXGEL team is constantly working to advance its mission of creating high-quality hydrogel products that can be worn by both consumers and patients for long periods of time with zero irritation,\u201d said Dr. Nelson. \u201cI look forward to joining the Scientific Advisory Board to further NEXGEL\u2019s pursuit in developing these novel solutions for new indications.\u201d<\/p>\n<p align=\"justify\">In addition to Dr. Nelson, Dr. Chesen is a board-certified ophthalmologist who has been in private practice at Chesen Laser Eye Center for 33 years, with extensive experience in cataract and LASIK procedures. He is also board-certified in internal medicine \u2013 one of only 40 physicians in the U.S. with this double board certification. Dr. Chesen received his bachelor\u2019s degree in biology from Lafayette College and Doctor of Medicine degree from Jefferson Medical College. He completed his residency in internal medicine at Einstein Medical Center in Philadelphia and residency in ophthalmology at Nassau University Medical Center in East Meadow, N.Y. Dr. Chesen has hospital privileges at the Reading Hospital \u2013 Tower Health, Penn State Health St. Joseph Medical Center, where he is chairman of the department of ophthalmology, and Surgical Institute of Reading, where he currently serves as Board Chairman. He is a member of the American Academy of Ophthalmology.<\/p>\n<p align=\"justify\">\u201cNEXGEL\u2019s high-water content hydrogel technology is extremely unique in that it is ultra-gentle on the skin and has numerous product applications across the entire healthcare landscape,\u201d added Dr. Chesen. \u201cThrough my decades of experience as an ophthalmologist, I see a lot of potential in these hydrogels for medicinal purposes, as well as the many others that NEXGEL currently has in its pipeline.\u201d<\/p>\n<p align=\"justify\">\u201cAs Drs. Chesen and Nelson are well-known leaders in the field of ophthalmology, NEXGEL will greatly benefit from their extensive medical knowledge and expertise as we continue to develop solutions using our hydrogels to help different kinds of patients around the U.S. and world,\u201d concluded Adam Levy, NEXGEL CEO.<\/p>\n<p align=\"justify\">\n        <strong>About NEXGEL, INC.<\/strong><br \/>\n        <br \/>NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Valter Pinto, Managing Director<br \/>KCSA Strategic Communications<br \/>212.896.1254<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7PaL3I9l70E21kdjsHH9fJ1FVdFSzYD_RBUxKdGo7eY5U9IIKgPw_pxKMQkeN0pOtlOBBUuyS06QipCCPFsTXw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>valter@kcsa.com<\/u><\/a><\/p>\n<p>\n        <strong>Media <\/strong><br \/>\n        <strong>Contacts:<\/strong><br \/>\n        <br \/>Raquel Cona \/ Michaela Fawcett<br \/>KCSA Strategic Communications<br \/>212.896.1204 \/ 978.995.4683<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qUnbOk3_e2Rbn6W2YppL6ZdzY0tmmQAo5V-5GPah8_B3IcexcmHZ_aCXKFdbm9FmvRZ58OkWA5S0DF6MKXephw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>rcona@kcsa.com<\/u><\/a> \/ <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QFgnETBfHY4rq1qmRcM1Heum_9ovBBeZp3xQxJy7U2LoH3-gzmnrI4kzvWci83PMYNAA_lmnprSqn9xL5vTLxw==\" rel=\"nofollow noopener\" target=\"_blank\">mfawcett@kcsa.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YWI1Y2E2ZTItOWEzOC00YjNhLThhM2UtMDg0NDQ0YzhmMzg2LTUwMDEwNjQzNw==\/tiny\/NEXGEL-INC-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LANGHORNE, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; NEXGEL, Inc. (\u201cNEXGEL\u201d or the \u201cCompany\u201d) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that the Company has appointed Dr. Neil Chesen and Dr. Leonard Nelson to its Scientific Advisory Board. Dr. Nelson serves as Co-Director of the pediatric ophthalmology department and Director of the Strabismus Center at Wills Eye Hospital. He is an associate professor of ophthalmology and pediatrics at Thomas Jefferson University\u2019s Sidney Kimmel Medical College and staff member at Thomas Jefferson University Hospital, Lankenau Medical Center and Children\u2019s Hospital of Philadelphia. Dr. Nelson previously served on staff at St. Christopher&#8217;s Hospital for Children. He earned a Doctor of Medicine &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-690145","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LANGHORNE, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; NEXGEL, Inc. (\u201cNEXGEL\u201d or the \u201cCompany\u201d) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that the Company has appointed Dr. Neil Chesen and Dr. Leonard Nelson to its Scientific Advisory Board. Dr. Nelson serves as Co-Director of the pediatric ophthalmology department and Director of the Strabismus Center at Wills Eye Hospital. He is an associate professor of ophthalmology and pediatrics at Thomas Jefferson University\u2019s Sidney Kimmel Medical College and staff member at Thomas Jefferson University Hospital, Lankenau Medical Center and Children\u2019s Hospital of Philadelphia. Dr. Nelson previously served on staff at St. Christopher&#8217;s Hospital for Children. He earned a Doctor of Medicine &hellip; Continue reading &quot;NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T11:33:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board\",\"datePublished\":\"2022-09-29T11:33:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/\"},\"wordCount\":668,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/\",\"name\":\"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==\",\"datePublished\":\"2022-09-29T11:33:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board - Market Newsdesk","og_description":"LANGHORNE, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; NEXGEL, Inc. (\u201cNEXGEL\u201d or the \u201cCompany\u201d) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that the Company has appointed Dr. Neil Chesen and Dr. Leonard Nelson to its Scientific Advisory Board. Dr. Nelson serves as Co-Director of the pediatric ophthalmology department and Director of the Strabismus Center at Wills Eye Hospital. He is an associate professor of ophthalmology and pediatrics at Thomas Jefferson University\u2019s Sidney Kimmel Medical College and staff member at Thomas Jefferson University Hospital, Lankenau Medical Center and Children\u2019s Hospital of Philadelphia. Dr. Nelson previously served on staff at St. Christopher&#8217;s Hospital for Children. He earned a Doctor of Medicine &hellip; Continue reading \"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-29T11:33:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board","datePublished":"2022-09-29T11:33:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/"},"wordCount":668,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/","name":"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==","datePublished":"2022-09-29T11:33:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NTUyNCM1MTc3OTkxIzUwMDEwNjQzNw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nexgel-appoints-dr-leonard-nelson-and-dr-neil-chesen-to-scientific-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=690145"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690145\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=690145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=690145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=690145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}